nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0442	0.0629	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0442	0.0629	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0381	0.0543	CbGbCtD
Zaleplon—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0381	0.0543	CbGbCtD
Zaleplon—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.037	0.0527	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.037	0.0527	CbGbCtD
Zaleplon—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0366	0.0522	CbGbCtD
Zaleplon—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0335	0.0476	CbGbCtD
Zaleplon—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0335	0.0476	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0335	0.0476	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0335	0.0476	CbGbCtD
Zaleplon—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0331	0.0472	CbGbCtD
Zaleplon—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0331	0.0472	CbGbCtD
Zaleplon—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0286	0.0407	CbGbCtD
Zaleplon—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0278	0.0395	CbGbCtD
Zaleplon—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0251	0.0357	CbGbCtD
Zaleplon—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0251	0.0357	CbGbCtD
Zaleplon—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0152	0.0216	CbGbCtD
Zaleplon—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0143	0.0203	CbGbCtD
Zaleplon—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0143	0.0203	CbGbCtD
Zaleplon—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0129	0.0184	CbGbCtD
Zaleplon—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0129	0.0184	CbGbCtD
Zaleplon—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0112	0.0159	CbGbCtD
Zaleplon—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0108	0.0154	CbGbCtD
Zaleplon—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00979	0.0139	CbGbCtD
Zaleplon—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00979	0.0139	CbGbCtD
Zaleplon—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00939	0.0134	CbGbCtD
Zaleplon—TSPO—blood plasma—acquired immunodeficiency syndrome	0.00174	0.0586	CbGeAlD
Zaleplon—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00108	0.0363	CbGeAlD
Zaleplon—TSPO—retina—acquired immunodeficiency syndrome	0.000952	0.0321	CbGeAlD
Zaleplon—TSPO—skin of body—acquired immunodeficiency syndrome	0.000836	0.0282	CbGeAlD
Zaleplon—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000808	0.0272	CbGeAlD
Zaleplon—AOX1—digestive system—acquired immunodeficiency syndrome	0.000783	0.0264	CbGeAlD
Zaleplon—GABRB2—spinal cord—acquired immunodeficiency syndrome	0.000726	0.0245	CbGeAlD
Zaleplon—GABRG2—spinal cord—acquired immunodeficiency syndrome	0.000726	0.0245	CbGeAlD
Zaleplon—AOX1—vagina—acquired immunodeficiency syndrome	0.000691	0.0233	CbGeAlD
Zaleplon—TSPO—lymphoid tissue—acquired immunodeficiency syndrome	0.000677	0.0228	CbGeAlD
Zaleplon—TSPO—digestive system—acquired immunodeficiency syndrome	0.000669	0.0225	CbGeAlD
Zaleplon—GABRB2—lung—acquired immunodeficiency syndrome	0.00066	0.0222	CbGeAlD
Zaleplon—AOX1—lung—acquired immunodeficiency syndrome	0.000654	0.022	CbGeAlD
Zaleplon—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.000641	0.0216	CbGeAlD
Zaleplon—GABRA2—vagina—acquired immunodeficiency syndrome	0.000638	0.0215	CbGeAlD
Zaleplon—TSPO—blood—acquired immunodeficiency syndrome	0.000637	0.0215	CbGeAlD
Zaleplon—TSPO—bone marrow—acquired immunodeficiency syndrome	0.000616	0.0208	CbGeAlD
Zaleplon—TSPO—spinal cord—acquired immunodeficiency syndrome	0.000614	0.0207	CbGeAlD
Zaleplon—GABRB2—nervous system—acquired immunodeficiency syndrome	0.000611	0.0206	CbGeAlD
Zaleplon—GABRG2—nervous system—acquired immunodeficiency syndrome	0.000611	0.0206	CbGeAlD
Zaleplon—TSPO—vagina—acquired immunodeficiency syndrome	0.00059	0.0199	CbGeAlD
Zaleplon—GABRB2—central nervous system—acquired immunodeficiency syndrome	0.000589	0.0198	CbGeAlD
Zaleplon—GABRG2—central nervous system—acquired immunodeficiency syndrome	0.000589	0.0198	CbGeAlD
Zaleplon—GABRA2—nervous system—acquired immunodeficiency syndrome	0.000559	0.0188	CbGeAlD
Zaleplon—TSPO—lung—acquired immunodeficiency syndrome	0.000558	0.0188	CbGeAlD
Zaleplon—GABRB3—spinal cord—acquired immunodeficiency syndrome	0.000557	0.0188	CbGeAlD
Zaleplon—GABRA1—nervous system—acquired immunodeficiency syndrome	0.00054	0.0182	CbGeAlD
Zaleplon—GABRA2—central nervous system—acquired immunodeficiency syndrome	0.000538	0.0181	CbGeAlD
Zaleplon—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.00052	0.0175	CbGeAlD
Zaleplon—TSPO—nervous system—acquired immunodeficiency syndrome	0.000517	0.0174	CbGeAlD
Zaleplon—GABRB3—lung—acquired immunodeficiency syndrome	0.000507	0.0171	CbGeAlD
Zaleplon—TSPO—central nervous system—acquired immunodeficiency syndrome	0.000498	0.0168	CbGeAlD
Zaleplon—GABRB3—nervous system—acquired immunodeficiency syndrome	0.000469	0.0158	CbGeAlD
Zaleplon—GABRG2—brain—acquired immunodeficiency syndrome	0.000467	0.0157	CbGeAlD
Zaleplon—GABRB2—brain—acquired immunodeficiency syndrome	0.000467	0.0157	CbGeAlD
Zaleplon—AOX1—brain—acquired immunodeficiency syndrome	0.000463	0.0156	CbGeAlD
Zaleplon—GABRB3—central nervous system—acquired immunodeficiency syndrome	0.000452	0.0152	CbGeAlD
Zaleplon—AOX1—lymph node—acquired immunodeficiency syndrome	0.000447	0.0151	CbGeAlD
Zaleplon—GABRA2—brain—acquired immunodeficiency syndrome	0.000427	0.0144	CbGeAlD
Zaleplon—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000414	0.014	CbGeAlD
Zaleplon—GABRA1—brain—acquired immunodeficiency syndrome	0.000413	0.0139	CbGeAlD
Zaleplon—GABRA2—lymph node—acquired immunodeficiency syndrome	0.000413	0.0139	CbGeAlD
Zaleplon—TSPO—brain—acquired immunodeficiency syndrome	0.000395	0.0133	CbGeAlD
Zaleplon—CYP3A5—blood—acquired immunodeficiency syndrome	0.000394	0.0133	CbGeAlD
Zaleplon—TSPO—lymph node—acquired immunodeficiency syndrome	0.000382	0.0129	CbGeAlD
Zaleplon—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000366	0.0123	CbGeAlD
Zaleplon—GABRB3—brain—acquired immunodeficiency syndrome	0.000359	0.0121	CbGeAlD
Zaleplon—CYP3A5—lung—acquired immunodeficiency syndrome	0.000346	0.0117	CbGeAlD
Zaleplon—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000311	0.0105	CbGeAlD
Zaleplon—CYP3A4—blood—acquired immunodeficiency syndrome	0.000296	0.00998	CbGeAlD
Zaleplon—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00024	0.0081	CbGeAlD
Zaleplon—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000231	0.0078	CbGeAlD
Zaleplon—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000459	CcSEcCtD
Zaleplon—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000458	CcSEcCtD
Zaleplon—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000458	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000457	CcSEcCtD
Zaleplon—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000457	CcSEcCtD
Zaleplon—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000122	0.000455	CcSEcCtD
Zaleplon—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000455	CcSEcCtD
Zaleplon—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000455	CcSEcCtD
Zaleplon—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000454	CcSEcCtD
Zaleplon—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000454	CcSEcCtD
Zaleplon—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000452	CcSEcCtD
Zaleplon—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000452	CcSEcCtD
Zaleplon—Rash—Didanosine—acquired immunodeficiency syndrome	0.000121	0.000451	CcSEcCtD
Zaleplon—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000451	CcSEcCtD
Zaleplon—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000121	0.000451	CcSEcCtD
Zaleplon—Headache—Didanosine—acquired immunodeficiency syndrome	0.00012	0.000448	CcSEcCtD
Zaleplon—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000448	CcSEcCtD
Zaleplon—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00012	0.000447	CcSEcCtD
Zaleplon—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000447	CcSEcCtD
Zaleplon—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000446	CcSEcCtD
Zaleplon—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000446	CcSEcCtD
Zaleplon—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000119	0.000446	CcSEcCtD
Zaleplon—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000445	CcSEcCtD
Zaleplon—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000445	CcSEcCtD
Zaleplon—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000444	CcSEcCtD
Zaleplon—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000444	CcSEcCtD
Zaleplon—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000443	CcSEcCtD
Zaleplon—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000442	CcSEcCtD
Zaleplon—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000442	CcSEcCtD
Zaleplon—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000442	CcSEcCtD
Zaleplon—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000441	CcSEcCtD
Zaleplon—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000441	CcSEcCtD
Zaleplon—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000118	0.000439	CcSEcCtD
Zaleplon—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000118	0.000439	CcSEcCtD
Zaleplon—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000439	CcSEcCtD
Zaleplon—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000438	CcSEcCtD
Zaleplon—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000438	CcSEcCtD
Zaleplon—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000438	CcSEcCtD
Zaleplon—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000438	CcSEcCtD
Zaleplon—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000437	CcSEcCtD
Zaleplon—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000436	CcSEcCtD
Zaleplon—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000436	CcSEcCtD
Zaleplon—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000435	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000435	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000434	CcSEcCtD
Zaleplon—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000433	CcSEcCtD
Zaleplon—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000433	CcSEcCtD
Zaleplon—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000433	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000432	CcSEcCtD
Zaleplon—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000432	CcSEcCtD
Zaleplon—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000429	CcSEcCtD
Zaleplon—Pain—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000429	CcSEcCtD
Zaleplon—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000429	CcSEcCtD
Zaleplon—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000429	CcSEcCtD
Zaleplon—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000428	CcSEcCtD
Zaleplon—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000427	CcSEcCtD
Zaleplon—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000427	CcSEcCtD
Zaleplon—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000427	CcSEcCtD
Zaleplon—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000426	CcSEcCtD
Zaleplon—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000426	CcSEcCtD
Zaleplon—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000114	0.000425	CcSEcCtD
Zaleplon—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000424	CcSEcCtD
Zaleplon—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000424	CcSEcCtD
Zaleplon—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000424	CcSEcCtD
Zaleplon—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000423	CcSEcCtD
Zaleplon—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000423	CcSEcCtD
Zaleplon—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000422	CcSEcCtD
Zaleplon—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000421	CcSEcCtD
Zaleplon—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000421	CcSEcCtD
Zaleplon—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000421	CcSEcCtD
Zaleplon—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00042	CcSEcCtD
Zaleplon—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.00042	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000419	CcSEcCtD
Zaleplon—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000418	CcSEcCtD
Zaleplon—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000416	CcSEcCtD
Zaleplon—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000415	CcSEcCtD
Zaleplon—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000414	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000414	CcSEcCtD
Zaleplon—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000413	CcSEcCtD
Zaleplon—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000412	CcSEcCtD
Zaleplon—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000412	CcSEcCtD
Zaleplon—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.000412	CcSEcCtD
Zaleplon—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000412	CcSEcCtD
Zaleplon—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000411	CcSEcCtD
Zaleplon—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000411	CcSEcCtD
Zaleplon—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000411	CcSEcCtD
Zaleplon—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.00041	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.00041	CcSEcCtD
Zaleplon—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000408	CcSEcCtD
Zaleplon—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000408	CcSEcCtD
Zaleplon—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000407	CcSEcCtD
Zaleplon—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000406	CcSEcCtD
Zaleplon—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000406	CcSEcCtD
Zaleplon—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000406	CcSEcCtD
Zaleplon—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000109	0.000406	CcSEcCtD
Zaleplon—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000109	0.000405	CcSEcCtD
Zaleplon—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000405	CcSEcCtD
Zaleplon—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000405	CcSEcCtD
Zaleplon—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000404	CcSEcCtD
Zaleplon—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000404	CcSEcCtD
Zaleplon—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000108	0.000403	CcSEcCtD
Zaleplon—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000402	CcSEcCtD
Zaleplon—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000402	CcSEcCtD
Zaleplon—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000402	CcSEcCtD
Zaleplon—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000401	CcSEcCtD
Zaleplon—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.0004	CcSEcCtD
Zaleplon—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.0004	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000399	CcSEcCtD
Zaleplon—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000399	CcSEcCtD
Zaleplon—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000397	CcSEcCtD
Zaleplon—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000397	CcSEcCtD
Zaleplon—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000397	CcSEcCtD
Zaleplon—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000397	CcSEcCtD
Zaleplon—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000396	CcSEcCtD
Zaleplon—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000395	CcSEcCtD
Zaleplon—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000393	CcSEcCtD
Zaleplon—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.000393	CcSEcCtD
Zaleplon—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.000393	CcSEcCtD
Zaleplon—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000392	CcSEcCtD
Zaleplon—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000392	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000392	CcSEcCtD
Zaleplon—Rash—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000392	CcSEcCtD
Zaleplon—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000391	CcSEcCtD
Zaleplon—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000391	CcSEcCtD
Zaleplon—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000391	CcSEcCtD
Zaleplon—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.00039	CcSEcCtD
Zaleplon—Headache—Stavudine—acquired immunodeficiency syndrome	0.000104	0.000389	CcSEcCtD
Zaleplon—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000389	CcSEcCtD
Zaleplon—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000388	CcSEcCtD
Zaleplon—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000388	CcSEcCtD
Zaleplon—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000388	CcSEcCtD
Zaleplon—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000387	CcSEcCtD
Zaleplon—Rash—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000386	CcSEcCtD
Zaleplon—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Zaleplon—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Zaleplon—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Zaleplon—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Zaleplon—Headache—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000383	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000382	CcSEcCtD
Zaleplon—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.000382	CcSEcCtD
Zaleplon—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000382	CcSEcCtD
Zaleplon—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.00038	CcSEcCtD
Zaleplon—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000379	CcSEcCtD
Zaleplon—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000378	CcSEcCtD
Zaleplon—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000378	CcSEcCtD
Zaleplon—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000377	CcSEcCtD
Zaleplon—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000377	CcSEcCtD
Zaleplon—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000375	CcSEcCtD
Zaleplon—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000375	CcSEcCtD
Zaleplon—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000374	CcSEcCtD
Zaleplon—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000374	CcSEcCtD
Zaleplon—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000374	CcSEcCtD
Zaleplon—Somnolence—Ritonavir—acquired immunodeficiency syndrome	9.99e-05	0.000373	CcSEcCtD
Zaleplon—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	9.98e-05	0.000373	CcSEcCtD
Zaleplon—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	9.94e-05	0.000371	CcSEcCtD
Zaleplon—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.91e-05	0.00037	CcSEcCtD
Zaleplon—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.89e-05	0.00037	CcSEcCtD
Zaleplon—Nausea—Stavudine—acquired immunodeficiency syndrome	9.88e-05	0.000369	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.86e-05	0.000368	CcSEcCtD
Zaleplon—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.84e-05	0.000367	CcSEcCtD
Zaleplon—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.78e-05	0.000365	CcSEcCtD
Zaleplon—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.77e-05	0.000365	CcSEcCtD
Zaleplon—Nausea—Abacavir—acquired immunodeficiency syndrome	9.73e-05	0.000363	CcSEcCtD
Zaleplon—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.71e-05	0.000363	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.7e-05	0.000362	CcSEcCtD
Zaleplon—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.65e-05	0.000361	CcSEcCtD
Zaleplon—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.65e-05	0.00036	CcSEcCtD
Zaleplon—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.64e-05	0.00036	CcSEcCtD
Zaleplon—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.64e-05	0.00036	CcSEcCtD
Zaleplon—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000359	CcSEcCtD
Zaleplon—Pain—Ritonavir—acquired immunodeficiency syndrome	9.61e-05	0.000359	CcSEcCtD
Zaleplon—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.61e-05	0.000359	CcSEcCtD
Zaleplon—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.61e-05	0.000359	CcSEcCtD
Zaleplon—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.61e-05	0.000359	CcSEcCtD
Zaleplon—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.56e-05	0.000357	CcSEcCtD
Zaleplon—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.52e-05	0.000356	CcSEcCtD
Zaleplon—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.51e-05	0.000355	CcSEcCtD
Zaleplon—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.4e-05	0.000351	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.4e-05	0.000351	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.34e-05	0.000349	CcSEcCtD
Zaleplon—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.33e-05	0.000349	CcSEcCtD
Zaleplon—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000346	CcSEcCtD
Zaleplon—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.26e-05	0.000346	CcSEcCtD
Zaleplon—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.25e-05	0.000345	CcSEcCtD
Zaleplon—Pain—Saquinavir—acquired immunodeficiency syndrome	9.25e-05	0.000345	CcSEcCtD
Zaleplon—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.2e-05	0.000344	CcSEcCtD
Zaleplon—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.19e-05	0.000343	CcSEcCtD
Zaleplon—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.17e-05	0.000343	CcSEcCtD
Zaleplon—Rash—Zidovudine—acquired immunodeficiency syndrome	9.11e-05	0.00034	CcSEcCtD
Zaleplon—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.11e-05	0.00034	CcSEcCtD
Zaleplon—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.11e-05	0.00034	CcSEcCtD
Zaleplon—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.08e-05	0.000339	CcSEcCtD
Zaleplon—Headache—Zidovudine—acquired immunodeficiency syndrome	9.06e-05	0.000338	CcSEcCtD
Zaleplon—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.99e-05	0.000336	CcSEcCtD
Zaleplon—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.97e-05	0.000335	CcSEcCtD
Zaleplon—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.93e-05	0.000333	CcSEcCtD
Zaleplon—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	8.91e-05	0.000333	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.91e-05	0.000333	CcSEcCtD
Zaleplon—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.89e-05	0.000332	CcSEcCtD
Zaleplon—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.88e-05	0.000332	CcSEcCtD
Zaleplon—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.88e-05	0.000332	CcSEcCtD
Zaleplon—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.00033	CcSEcCtD
Zaleplon—Pain—Lamivudine—acquired immunodeficiency syndrome	8.82e-05	0.00033	CcSEcCtD
Zaleplon—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.82e-05	0.00033	CcSEcCtD
Zaleplon—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.72e-05	0.000326	CcSEcCtD
Zaleplon—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.6e-05	0.000321	CcSEcCtD
Zaleplon—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.59e-05	0.000321	CcSEcCtD
Zaleplon—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.59e-05	0.000321	CcSEcCtD
Zaleplon—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.55e-05	0.000319	CcSEcCtD
Zaleplon—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.55e-05	0.000319	CcSEcCtD
Zaleplon—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.5e-05	0.000318	CcSEcCtD
Zaleplon—Rash—Indinavir—acquired immunodeficiency syndrome	8.48e-05	0.000317	CcSEcCtD
Zaleplon—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.47e-05	0.000316	CcSEcCtD
Zaleplon—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000315	CcSEcCtD
Zaleplon—Headache—Indinavir—acquired immunodeficiency syndrome	8.42e-05	0.000315	CcSEcCtD
Zaleplon—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.4e-05	0.000314	CcSEcCtD
Zaleplon—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.2e-05	0.000306	CcSEcCtD
Zaleplon—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.16e-05	0.000305	CcSEcCtD
Zaleplon—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.16e-05	0.000305	CcSEcCtD
Zaleplon—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.06e-05	0.000301	CcSEcCtD
Zaleplon—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.04e-05	0.0003	CcSEcCtD
Zaleplon—Rash—Efavirenz—acquired immunodeficiency syndrome	8.01e-05	0.000299	CcSEcCtD
Zaleplon—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8e-05	0.000299	CcSEcCtD
Zaleplon—Nausea—Indinavir—acquired immunodeficiency syndrome	7.99e-05	0.000298	CcSEcCtD
Zaleplon—Headache—Efavirenz—acquired immunodeficiency syndrome	7.96e-05	0.000297	CcSEcCtD
Zaleplon—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.95e-05	0.000297	CcSEcCtD
Zaleplon—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.76e-05	0.00029	CcSEcCtD
Zaleplon—Rash—Delavirdine—acquired immunodeficiency syndrome	7.66e-05	0.000286	CcSEcCtD
Zaleplon—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.66e-05	0.000286	CcSEcCtD
Zaleplon—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.65e-05	0.000286	CcSEcCtD
Zaleplon—Headache—Delavirdine—acquired immunodeficiency syndrome	7.61e-05	0.000284	CcSEcCtD
Zaleplon—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.54e-05	0.000282	CcSEcCtD
Zaleplon—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.43e-05	0.000278	CcSEcCtD
Zaleplon—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.4e-05	0.000277	CcSEcCtD
Zaleplon—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.3e-05	0.000273	CcSEcCtD
Zaleplon—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.22e-05	0.00027	CcSEcCtD
Zaleplon—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000267	CcSEcCtD
Zaleplon—Rash—Ritonavir—acquired immunodeficiency syndrome	7.09e-05	0.000265	CcSEcCtD
Zaleplon—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.08e-05	0.000264	CcSEcCtD
Zaleplon—Headache—Ritonavir—acquired immunodeficiency syndrome	7.04e-05	0.000263	CcSEcCtD
Zaleplon—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000255	CcSEcCtD
Zaleplon—Rash—Saquinavir—acquired immunodeficiency syndrome	6.82e-05	0.000255	CcSEcCtD
Zaleplon—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.81e-05	0.000255	CcSEcCtD
Zaleplon—Headache—Saquinavir—acquired immunodeficiency syndrome	6.78e-05	0.000253	CcSEcCtD
Zaleplon—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.68e-05	0.000249	CcSEcCtD
Zaleplon—Rash—Lamivudine—acquired immunodeficiency syndrome	6.51e-05	0.000243	CcSEcCtD
Zaleplon—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.5e-05	0.000243	CcSEcCtD
Zaleplon—Headache—Lamivudine—acquired immunodeficiency syndrome	6.46e-05	0.000241	CcSEcCtD
Zaleplon—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.43e-05	0.00024	CcSEcCtD
Zaleplon—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.13e-05	0.000229	CcSEcCtD
